ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for AMGEN
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to Medicare Part B coverage and reimbursement, generally Issues related to Medicare Part D, generally Coding and reimbursement for oncology drugs/biologics/biosimilars
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Health Issues HCR
Issues related to biosimilars, generally Issues related to drug pricing, value, and transparency, generally Issues related to the importation of prescription medicines Issues related to International Pricing Index; Most Favored Nation drug pricing Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Taxation/Internal Revenue Code TAX
Tax issues related to supply chain; Puerto Rico
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.